Compare
ASTH vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| ASTH | SPY | |
|---|---|---|
| Price | $34.50 | $735.29 |
| 1-day | -11.56% | +0.31% |
| YTD | +39.06% | +7.83% |
| 1 year | +3.79% | +8.52% |
| 3 years | +13.82% | +73.97% |
| Market cap | $1.9B | — |
| P/E | 31.9 | — |
| P/S | 0.49 | — |
| P/B | 2.25 | — |
| Revenue growth | +35.10% | — |
| EPS growth | +440.00% | — |
| Gross margin % | 11.0 | — |
| Net margin % | 1.4 | — |
| ROE % | 6.2 | — |
| Debt / equity | 1.08 | — |
| FCF yield % | 5.2 | — |
| Dividend yield % | — | — |
| Beta | 0.59 | 1.00 |
| RSI (14) | 39.8 | 35.1 |
| Technical rating |